Clinical trial
KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
NCT03779282 is registered in ClinicalTrials.gov with Ochsner Health System as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- KETODEX for Emergence Delirium in Children Undergoing Outpatient Strabismus Surgery
- Lead sponsor
- Ochsner Health System
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 15, 2018
- Completion date
- September 15, 2018
- Enrollment
- 90 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.